PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Hyperglycemic Mice Increases the Risk of Hemorrhagic Transformation of Ischemic Stroke.
PubMed 文献 · Stroke · 2021-07-28
[Figure: see text].
引用
- Nativel B, Ramin-Mangata S, Couret D, et al. PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Hyperglycemic Mice Increases the Risk of Hemorrhagic Transformation of Ischemic Stroke. Stroke. 2021. PMID: 34315254. doi:10.1161/STROKEAHA.121.035677
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。